tert-Butyl 5-amino-3,3-difluoropiperidine-1-carboxylate

Catalog No. :
ACJPYM984
CAS No. :
1258638-82-2
Molecular Formula :
C10H18F2N2O2
Molecular Weight :
236.26

IUPAC Name:tert-butyl 5-amino-3,3-difluoropiperidine-1-carboxylate

tert-Butyl 5-amino-3,3-difluoropiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$67.00Login to see priceIn stockInquiry
1g98%$220.00Login to see priceIn stockInquiry
5g98%$953.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 5-amino-3,3-difluoropiperidine-1-carboxylate
IUPAC Nametert-butyl 5-amino-3,3-difluoropiperidine-1-carboxylate
MDL No.MFCD18433745
Molecular FormulaC10H18F2N2O2
Molecular Weight236.26
SMILESO=C(N1CC(F)(F)CC(N)C1)OC(C)(C)C
InChI KeyYHFQRFDPXSAJPK-UHFFFAOYSA-N
Synonymtert-butyl 5-aMino-3,3-difluoropiperidine-1-carboxylate;5-AMino-1-Boc-3,3-difluoropiperidine;1-Piperidinecarboxylic acid, 5-amino-3,3-difluoro-, 1,1-dimethylethyl ester;5-Amino-3,3-difluoro-piperidine-1-carboxylic acid tert-butyl ester;3-Amino-1-Boc-5,5-difluoropiperidine
CAS No.1258638-82-2
PubChem CID72207300

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJPYM984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJPYM984 route product structure diagram
    ACJPYM9841258638-82-2 In Stock
Inquiry

2. ACJPYM984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACJPYM984 route product structure diagram
    ACJPYM9841258638-82-2 In Stock
Inquiry

Comments (0)